Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

American Society for Bone and Mineral Research-Orthopaedic Research Society Joint Task Force Report on Cell-Based Therapies.

O'Keefe RJ, Tuan RS, Lane NE, Awad HA, Barry F, Bunnell BA, Colnot C, Drake MT, Drissi H, Dyment NA, Fortier LA, Guldberg RE, Kandel R, Little DG, Marshall MF, Mao JJ, Nakamura N, Proffen BL, Rodeo SA, Rosen V, Thomopoulos S, Schwarz EM, Serra R.

J Bone Miner Res. 2019 Sep 23. doi: 10.1002/jbmr.3839. [Epub ahead of print]

PMID:
31545883
2.

Lung tumor cells inhibit bone mineralization and osteoblast activity.

Berent TE, Dorschner JM, Craig TA, Drake MT, Westendorf JJ, Kumar R.

Biochem Biophys Res Commun. 2019 Nov 12;519(3):566-571. doi: 10.1016/j.bbrc.2019.09.045. Epub 2019 Sep 16.

PMID:
31537378
3.

Drugs for the treatment of metabolic bone diseases.

Drake MT, Cremers S, Russell RG, Bilezikian JP.

Br J Clin Pharmacol. 2019 Jun;85(6):1049-1051. doi: 10.1111/bcp.13857. Epub 2019 Apr 4. No abstract available.

PMID:
30950086
4.

The skeletal impact of cancer therapies.

Bedatsova L, Drake MT.

Br J Clin Pharmacol. 2019 Jun;85(6):1161-1168. doi: 10.1111/bcp.13866. Epub 2019 Feb 21. Review.

PMID:
30723928
5.

Pharmacology of bisphosphonates.

Cremers S, Drake MT, Ebetino FH, Bilezikian JP, Russell RGG.

Br J Clin Pharmacol. 2019 Jun;85(6):1052-1062. doi: 10.1111/bcp.13867. Epub 2019 Feb 28. Review.

PMID:
30650219
6.

Hypothyroidism in Clinical Practice.

Drake MT.

Mayo Clin Proc. 2018 Sep;93(9):1169-1172. doi: 10.1016/j.mayocp.2018.07.015. No abstract available. Erratum in: Mayo Clin Proc. 2018 Dec;93(12):1876.

PMID:
30193671
7.

Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism.

Khosla S, Drake MT, Volkman TL, Thicke BS, Achenbach SJ, Atkinson EJ, Joyner MJ, Rosen CJ, Monroe DG, Farr JN.

J Clin Invest. 2018 Nov 1;128(11):4832-4842. doi: 10.1172/JCI122151. Epub 2018 Oct 2.

8.

Failing Kidneys and Thyroid Dysfunction-An Undesirable Synergy.

Stan MN, Drake MT.

Mayo Clin Proc. 2018 May;93(5):555-557. doi: 10.1016/j.mayocp.2018.03.027. No abstract available.

PMID:
29728198
9.

Evaluation of cross-sectional and longitudinal changes in volumetric bone mineral density in postmenopausal women using single- versus dual-energy quantitative computed tomography.

Sfeir JG, Drake MT, Atkinson EJ, Achenbach SJ, Camp JJ, Tweed AJ, McCready LK, Yu L, Adkins MC, Amin S, Khosla S.

Bone. 2018 Jul;112:145-152. doi: 10.1016/j.bone.2018.04.023. Epub 2018 Apr 25.

10.

Vertebral compression fractures associated with yoga: a case series.

Sfeir JG, Drake MT, Sonawane VJ, Sinaki M.

Eur J Phys Rehabil Med. 2018 Dec;54(6):947-951. doi: 10.23736/S1973-9087.18.05034-7. Epub 2018 Apr 24.

11.

Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments.

Drake MT, Fenske JS, Blocki FA, Zierold C, Appelman-Dijkstra N, Papapoulos S, Khosla S.

Bone. 2018 Jun;111:36-43. doi: 10.1016/j.bone.2018.03.013. Epub 2018 Mar 14.

12.

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

Inwards DJ, Fishkin PA, LaPlant BR, Drake MT, Kurtin PJ, Nikcevich DA, Wender DB, Lair BS, Witzig TE.

Ann Oncol. 2019 Feb 1;30(2):346. doi: 10.1093/annonc/mdx814. No abstract available.

13.

Corrigendum: Targeting cellular senescence prevents age-related bone loss in mice.

Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB, Hachfeld CM, LeBrasseur NK, Drake MT, Pignolo RJ, Pirtskhalava T, Tchkonia T, Oursler MJ, Kirkland JL, Khosla S.

Nat Med. 2017 Nov 7;23(11):1384. doi: 10.1038/nm1117-1384c.

PMID:
29117174
14.

Our Evolving Understanding of the Relationship Between Diabetes and Bone.

Kotwal A, Drake MT.

Am J Med Sci. 2017 Oct;354(4):333-334. doi: 10.1016/j.amjms.2017.08.016. Epub 2017 Sep 1. Review. No abstract available.

PMID:
29078835
15.

Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study.

Kumar S, Drake MT, Schleck CD, Johnson ML, Alexander JA, Katzka DA, Iyer PG.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1094-1102. doi: 10.1111/apt.14345. Epub 2017 Oct 5.

16.

Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density.

Lapid MI, Kung S, Frye MA, Biernacka JM, Geske JR, Drake MT, Jankowski MD, Clarke BL.

Transl Psychiatry. 2017 Aug 22;7(8):e1213. doi: 10.1038/tp.2017.184.

17.

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma.

Tracy SI, Maurer MJ, Witzig TE, Drake MT, Ansell SM, Nowakowski GS, Thompson CA, Inwards DJ, Johnston PB, Micallef IN, Allmer C, Macon WR, Weiner GJ, Slager SL, Habermann TM, Link BK, Cerhan JR.

Blood Cancer J. 2017 Aug 25;7(8):e595. doi: 10.1038/bcj.2017.70.

18.

Targeting cellular senescence prevents age-related bone loss in mice.

Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB, Hachfeld CM, LeBrasseur NK, Drake MT, Pignolo RJ, Pirtskhalava T, Tchkonia T, Oursler MJ, Kirkland JL, Khosla S.

Nat Med. 2017 Sep;23(9):1072-1079. doi: 10.1038/nm.4385. Epub 2017 Aug 21. Erratum in: Nat Med. 2017 Nov 7;23 (11):1384.

19.

Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation.

Ammann EM, Drake MT, Haraldsson B, Wallace RB, Johnson KC, Desai P, Lin EM, Link BK.

Cancer. 2017 Nov 1;123(21):4168-4177. doi: 10.1002/cncr.30858. Epub 2017 Jun 27.

20.

Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned.

Drake MT, Clarke BL, Oursler MJ, Khosla S.

Endocr Rev. 2017 Aug 1;38(4):325-350. doi: 10.1210/er.2015-1114. Review.

21.

A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.

Lwin ST, Fowler JA, Drake MT, Edwards JR, Lynch CC, Edwards CM.

Mol Cancer. 2017 Feb 28;16(1):49. doi: 10.1186/s12943-017-0616-9.

22.

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.

Sfeir JG, Drake MT, LaPlant BR, Maurer MJ, Link BK, Berndt TJ, Shanafelt TD, Cerhan JR, Habermann TM, Feldman AL, Witzig T.

Blood Cancer J. 2017 Feb 3;7(2):e526. doi: 10.1038/bcj.2017.9. No abstract available.

23.

The Rare Bone Disease Working Group: report from the 2016 American Society for Bone and Mineral Research Annual Meeting.

Drake MT, Collins MT, Hsiao EC.

Bone. 2017 Sep;102:80-84. doi: 10.1016/j.bone.2017.01.021. Epub 2017 Jan 20.

PMID:
28115283
24.

Sclerostin: From bedside to bench, and back to bedside.

Robling AG, Drake MT, Papapoulos SE.

Bone. 2017 Mar;96:1-2. doi: 10.1016/j.bone.2017.01.019. Epub 2017 Jan 20. No abstract available.

PMID:
28115280
25.

Hormonal and systemic regulation of sclerostin.

Drake MT, Khosla S.

Bone. 2017 Mar;96:8-17. doi: 10.1016/j.bone.2016.12.004. Epub 2016 Dec 10. Review.

26.

Identification of Senescent Cells in the Bone Microenvironment.

Farr JN, Fraser DG, Wang H, Jaehn K, Ogrodnik MB, Weivoda MM, Drake MT, Tchkonia T, LeBrasseur NK, Kirkland JL, Bonewald LF, Pignolo RJ, Monroe DG, Khosla S.

J Bone Miner Res. 2016 Nov;31(11):1920-1929. doi: 10.1002/jbmr.2892. Epub 2016 Oct 24.

27.

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE.

J Bone Miner Res. 2016 Oct;31(10):1910. doi: 10.1002/jbmr.2918. Epub 2016 Jul 26. No abstract available.

28.

Optimizing Insulin Delivery in Patients With Diabetes Mellitus: Still Room for Improvement.

Drake MT, Smith SA.

Mayo Clin Proc. 2016 Sep;91(9):1155-7. doi: 10.1016/j.mayocp.2016.07.010. No abstract available.

PMID:
27594182
29.

Commentary.

Drake MT.

Clin Chem. 2016 May;62(5):687-8. doi: 10.1373/clinchem.2015.248757. No abstract available.

30.

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.

Siontis B, Kumar S, Dispenzieri A, Drake MT, Lacy MQ, Buadi F, Dingli D, Kapoor P, Gonsalves W, Gertz MA, Rajkumar SV.

Blood Cancer J. 2015 Oct 23;5:e364. doi: 10.1038/bcj.2015.87.

31.

Deletion of Estrogen Receptor Beta in Osteoprogenitor Cells Increases Trabecular but Not Cortical Bone Mass in Female Mice.

Nicks KM, Fujita K, Fraser D, McGregor U, Drake MT, McGee-Lawrence ME, Westendorf JJ, Monroe DG, Khosla S.

J Bone Miner Res. 2016 Mar;31(3):606-14. doi: 10.1002/jbmr.2723. Epub 2015 Oct 13.

32.

Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing.

Farr JN, Roforth MM, Fujita K, Nicks KM, Cunningham JM, Atkinson EJ, Therneau TM, McCready LK, Peterson JM, Drake MT, Monroe DG, Khosla S.

PLoS One. 2015 Sep 24;10(9):e0138347. doi: 10.1371/journal.pone.0138347. eCollection 2015.

33.

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE.

J Bone Miner Res. 2016 Jan;31(1):16-35. doi: 10.1002/jbmr.2708. Review. Erratum in: J Bone Miner Res. 2016 Oct;31(10 ):1910.

34.

Teriparatide Therapy and Reduced Postoperative Hospitalization for Postsurgical Hypoparathyroidism.

Shah M, Bancos I, Thompson GB, Richards ML, Kasperbauer JL, Clarke BL, Drake MT, Stan MN.

JAMA Otolaryngol Head Neck Surg. 2015 Sep;141(9):822-7. doi: 10.1001/jamaoto.2015.1497.

PMID:
26312597
35.

Early Hypoparathyroidism Reversibility with Treatment of Riedel's Thyroiditis.

Stan MN, Haglind EG, Drake MT.

Thyroid. 2015 Sep;25(9):1055-9. doi: 10.1089/thy.2015.0212. Epub 2015 Aug 17.

PMID:
26200816
36.

The Pathophysiology and Treatment of Osteoporosis.

Drake MT, Clarke BL, Lewiecki EM.

Clin Ther. 2015 Aug;37(8):1837-50. doi: 10.1016/j.clinthera.2015.06.006. Epub 2015 Jul 7. Review.

PMID:
26163201
37.

Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women.

Roforth MM, Farr JN, Fujita K, McCready LK, Atkinson EJ, Therneau TM, Cunningham JM, Drake MT, Monroe DG, Khosla S.

Bone. 2015 Jul;76:49-57. doi: 10.1016/j.bone.2015.03.017. Epub 2015 Mar 27.

38.

62-year-old man with persistent postoperative nausea and vomiting.

Al Bawardy BF, Simonetto DA, Drake MT.

Mayo Clin Proc. 2015 Feb;90(2):280-3. doi: 10.1016/j.mayocp.2014.06.023. No abstract available.

PMID:
25659244
39.

Predictors of teriparatide treatment failure in patients with low bone mass.

Elraiyah T, Ahmed AH, Wang Z, Farr JN, Murad MH, Drake MT.

Bone Rep. 2015 Nov 17;4:17-22. doi: 10.1016/j.bonr.2015.11.001. eCollection 2016 Jun.

40.

unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance?

Drake MT.

J Bone Miner Res. 2014 Dec;29(12):2529-33. doi: 10.1002/jbmr.2387. Review.

41.

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

Inwards DJ, Fishkin PA, LaPlant BR, Drake MT, Kurtin PJ, Nikcevich DA, Wender DB, Lair BS, Witzig TE.

Ann Oncol. 2014 Oct;25(10):2020-4. doi: 10.1093/annonc/mdu273. Epub 2014 Jul 23. Erratum in: Ann Oncol. 2019 Feb 1;30(2):346.

42.

Inhibitors of sclerostin: emerging concepts.

Drake MT, Farr JN.

Curr Opin Rheumatol. 2014 Jul;26(4):447-52. doi: 10.1097/BOR.0000000000000073. Review.

43.

Vitamin D and the goldilocks principle: too little, too much, or just right?

Drake MT.

J Clin Endocrinol Metab. 2014 Apr;99(4):1164-6. doi: 10.1210/jc.2014-1350. No abstract available.

44.

Clinical utility of serum sclerostin measurements.

Clarke BL, Drake MT.

Bonekey Rep. 2013 Jun 5;2:361. doi: 10.1038/bonekey.2013.95. eCollection 2013. Review.

45.

Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance.

Farr JN, Zhang W, Kumar SK, Jacques RM, Ng AC, McCready LK, Rajkumar SV, Drake MT.

Blood. 2014 Jan 30;123(5):647-9. doi: 10.1182/blood-2013-05-505776. Epub 2013 Nov 13.

46.

Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.

Roforth MM, Fujita K, McGregor UI, Kirmani S, McCready LK, Peterson JM, Drake MT, Monroe DG, Khosla S.

Bone. 2014 Feb;59:1-6. doi: 10.1016/j.bone.2013.10.019. Epub 2013 Oct 29.

47.

Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women.

Fujita K, Roforth MM, Demaray S, McGregor U, Kirmani S, McCready LK, Peterson JM, Drake MT, Monroe DG, Khosla S.

J Clin Endocrinol Metab. 2014 Jan;99(1):E81-8. doi: 10.1210/jc.2013-3249. Epub 2013 Dec 20.

48.

In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Farr JN, Drake MT, Amin S, Melton LJ 3rd, McCready LK, Khosla S.

J Bone Miner Res. 2014 Apr;29(4):787-95. doi: 10.1002/jbmr.2106.

49.

Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture.

Fujita K, Roforth MM, Atkinson EJ, Peterson JM, Drake MT, McCready LK, Farr JN, Monroe DG, Khosla S.

Osteoporos Int. 2014 Mar;25(3):887-95. doi: 10.1007/s00198-013-2529-9. Epub 2013 Oct 11.

50.

Vitamin D in the cancer patient.

Kennel KA, Drake MT.

Curr Opin Support Palliat Care. 2013 Sep;7(3):272-7. doi: 10.1097/SPC.0b013e3283640f74. Review.

Supplemental Content

Loading ...
Support Center